Rachel Galot

Liquid biopsy for mutational profiling of locoregional recurrent and/or metastatic head and neck squamous cell carcinoma

Rachel Galot, Cédric van Marcke, Raphaël Helaers et al. · Oral Oncology · 2020 · 65 citations · Full text

Medicine, Oncology, Pathology +17

A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial

Rachel Galot, Christophe Le Tourneau, Esma Saâda-Bouzid et al. · European Journal of Cancer · 2021 · 54 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Tumor-agnostic plasma assay for circulating tumor DNA detects minimal residual disease and predicts outcome in locally advanced squamous cell carcinoma of the head and neck

Natasha Honoré, Cédric van Marcke, Rachel Galot et al. · Annals of Oncology · 2023 · 50 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors

Babar Bashir, Judy S. Wang, Gerald S. Falchook et al. · Journal of Clinical Oncology · 2024 · 19 citations · Full text

Medicine, Oncology, Pharmacology +15

Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid Tumors

Valentina Gambardella, Michael Ong, María E. Rodríguez-Ruiz et al. · Cancer Research Communications · 2025 · 16 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17